Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphomaRena Buckstein, Robert S Kerbel, Yuval Shaked, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.European Journal of Cancer (Oxford, England : 1990)|June 10, 2009
A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumoursSylvain Baruchel, Julia R Sharp, Ute Bartels, et al.Cancer Research|April 19, 2006
Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signalingAlice Lee, Jason Frischer, Anna Serur, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group StudyJulia L Glade Bender, Peter C Adamson, Joel M Reid, et al.Pageof 2